MUSTANG BIO, INC. Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31)
MUSTANG BIO, INC. (MBIO) reported Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) of 1.60% for the 9-month period ending 2016-09-30, per its 10-Q filed 2016-11-14.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:FairValueAssumptionsRiskFreeInterestRate · last filed 2016-11-14
- 2016-09-30: Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 9 month 1.60%.
- 2016-07-05: Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 0 month 1.37%.
| Period end | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 0 month | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 9 month |
|---|---|---|
| 2016-09-30 | 1.60% 10-Q · filed 2016-11-14 | |
| 2016-07-05 | 1.37% 10-Q · filed 2016-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |